Schedule 13G ownership disclosure
N/A
COMMON STOCK · CUSIP: 449585108
Event date: 2025-01-31
- Filing-level shares
- 65,940
- Percent of class
- 0.2%
- T. Rowe Price Associates, Inc.
Shares: 65,940 · Class: 0.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-25-000162
- Form type
- SCHEDULE 13G/A
- Filer
- IGM Biosciences, Inc.
- CIK
- CIK 1496323
- Filed
- Feb 07, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13G beneficial ownership